Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
f , Relative GSSG abundance in ER isolated from Slc33a1- knockout KPK cells expressing wild-type SLC33A1 , disease-associated SLC33A1 variants, or vector control
Regular monitoring and follow-up enable timely dose adjustments and identification of any safety concerns
What to do if side effects are a barrier Nausea and diarrhea are the most common reasons patients stay at a lower step longer or ask about pausing escalation
How to Administer the Retatrutide Starting Dose Retatrutide is given as a subcutaneous injection once weekly
Tirzepatide became the first dual GLP/GLP-1 receptor agonist to gain FDA approval for treating T2DM in 2022 and obesity in 2023 [ Table 2 ]
